TrialJournal of the National Cancer Institute2025

Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial.

Yara Abdou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.